| manager |
|
| language |
- |
| license |
- |
| created at |
2017-12-21 11:07:16 UTC |
| updated at |
2017-12-21 12:22:32 UTC |
|
2 layers
|
143,100 entries
|
There is 0 pattern entry.
|
FDA RPS Pharmacology: Secondary Pharmacodynamics
|
CONC:NCI_CDISC |
|
|
FDA RPS Reproductive And Developmental Toxicity: Embryofetal Development
|
CONC:NCI_CDISC |
|
|
EMBRYO FETAL DEVELOPMENT
|
CONC:NCI_CDISC |
|
|
FDA RPS Reproductive And Developmental Toxicity: Fertility And Early Embryonic Development
|
CONC:NCI_CDISC |
|
|
FERTILITY AND EARLY EMBRYONIC DEVELOPMENT
|
CONC:NCI_CDISC |
|
|
FDA RPS Reproductive And Developmental Toxicity: Prenatal And Postnatal Development Including Maternal Function
|
CONC:NCI_CDISC |
|
|
PRENATAL AND POSTNATAL DEVELOPMENT
|
CONC:NCI_CDISC |
|
|
JUVENILE STUDIES
|
CONC:NCI_CDISC |
|
|
FDA RPS Studies In Which The Offspring (Juvenile Animals) Are Dosed And/Or Further Evaluated
|
CONC:NCI_CDISC |
|
|
FDA RPS Pharmacokinetics: Excretion
|
CONC:NCI_CDISC |
|
|
EXCRETION
|
CONC:NCI_CDISC |
|
|
CARCINOGENICITY
|
CONC:NCI_CDISC |
|
|
FDA RPS Toxicology: Carcinogenicity
|
CONC:NCI_CDISC |
|
|
LOCAL TOLERANCE
|
CONC:NCI_CDISC |
|
|
FDA RPS Toxicology: Local Tolerance
|
CONC:NCI_CDISC |
|
